We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The head of the largest U.S. drug manufacturing trade group is pushing back against critics who claim drug prices are too high, particularly for some new hepatitis C drugs that can cost up to $1,000 per pill.